A matter of months after possession of psilocybin mushrooms was decriminalized in Denver, Colorado and Oakland, California, another major step has been made in their road to public accessibility. The U.S. Food and Drug Administration (FDA) has given the entheogenic a "Breakthrough Treatment" designation, opening doors for further research into the substance's benefits for sufferers of major depressive disorder (MDD), better known simply as depression.

The designation acknowledges the strong preliminary evidence showing psilocybin's treatment potential for depression and offers "intensive guidance" from the FDA. It's the second time in just over a year that psilocybin was granted such a status; the last time was in October of 2018 after COMPASS Pathways determined the compound to aid those suffering from treatment-resistant depression. 

Nonprofit research organization Usona Institute recently commenced a Phase 2 clinical trial in which 80 people will take a single, one-time dose of psilocybin orally. The purpose of the trial will be to determine how effectively the compound treats depression. 

Researchers have been quick to point out that those with depression should not self-medicate with psilocybin as it is easy to confuse mushroom strains and difficult to determine proper dosage. Even in decriminalized cities, psilocybin mushrooms are still technically illegal by state and federal law throughout the U.S. 

Recommended Articles

Yvonne Gougelet Kyle Kinch-24

Get Down to Kyle Kinch's Poolside Tech House Anthem, "Rumpshaker"

The song invites you to sweat with an infectious vocal refrain and chugging bassline.

lsdream

LSDREAM Announces New Album, Drops Wobbly Single "PEACE LOVE & WUBZ": Listen

LSDREAM's third album will drop on his familiar home of Wakaan.

moore kismet

Moore Kismet Makes History As Youngest Artist to Ever Perform at Lollapalooza

"I’m still at a loss for words at how great this felt."

H/T: Popular Science

Related

kacey musgraves

Kacey Musgraves Lists Daft Punk, Magic Mushrooms as Influences of Upcoming Album

The six-time Grammy Award winner recently spilled the tea on the influences behind her forthcoming feature-length album, due later this year.

Psilocybin Mushrooms

Mind Medicine and Other Psychedelics Companies Looking to Go Public in 2020

Amid psilocybin mushrooms' decriminalization in more and more U.S. cities, psychedelics are going corporate.

i_o

Death of i_o Revealed to Be a Result of Natural Causes

The Los Angeles County Department of Medical Examiner-Coroner's report listed a thyroid disorder as i_o's cause of death.

Music Festival Audience

10 Symptoms of Post-Music Festival Depression

Here's How You Know You're Suffering From Post-Music Festival Depression

Porter Robinson

Porter Robinson Opens Up About Overcoming Depression to Produce "Nurture"

"The album came after a real kind of emotional and creative low point for me, where I just was genuinely feeling like I was not capable of making music anymore."

Adele

Musicians are Three Times More Likely to be Depressed, Study Finds

MusicTank and the University of Westminister found that 68.5% of respondents stated they experienced depression.

Virtual Riot

RIOT Premieres Remix of Infected Mushroom's Banger 'U R So F--ked'

Infected Mushroom received treatment from Los Angeles hellraisers.